About lab
Modified model of losartan metabolism (Karatza and Karalis, 2020) incorporating different allelic variants of CYP2C9. It can be used to explore metabolic flux dynamics and compare pathway behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagebabaev2024-cyp2c9-variants-lab
Created2026-05-15
Updated2026-05-15
biomodels_ebifaithfulmetabolismodesbmltelluriumvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_drug_metabolite_e3174",
"units": "native SBML value",
"default": 0,
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.initial_drug_metabolite_e3174",
"description": "Initial condition for drug metabolite e3174. Maps to bundled SBML symbol `E3174_out`. Applied before the Tellurium simulation starts; this does not change kinetic parameters or equations. Default from bundled SBML initial value."
},
{
"name": "initial_drug_metabolite_e3174_2",
"units": "native SBML value",
"default": 0,
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.initial_drug_metabolite_e3174_2",
"description": "Initial condition for drug metabolite e3174 2. Maps to bundled SBML symbol `E3174_cc`. Applied before the Tellurium simulation starts; this does not change kinetic parameters or equations. Default from bundled SBML initial value."
},
{
"name": "initial_drug_metabolism_state_3",
"units": "native SBML value",
"default": 0,
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.initial_drug_metabolism_state_3",
"description": "Initial condition for drug metabolism state 3. Maps to bundled SBML symbol `losartan_cc`. Applied before the Tellurium simulation starts; this does not change kinetic parameters or equations. Default from bundled SBML initial value."
},
{
"name": "initial_drug_metabolism_state_4",
"units": "native SBML value",
"default": 0,
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.initial_drug_metabolism_state_4",
"description": "Initial condition for drug metabolism state 4. Maps to bundled SBML symbol `losartan_int`. Applied before the Tellurium simulation starts; this does not change kinetic parameters or equations. Default from bundled SBML initial value."
},
{
"name": "initial_drug_metabolism_state_5_extracellular",
"units": "native SBML value",
"default": 0,
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.initial_drug_metabolism_state_5_extracellular",
"description": "Initial condition for drug metabolism state 5 extracellular. Maps to bundled SBML symbol `losartan_out`. Applied before the Tellurium simulation starts; this does not change kinetic parameters or equations. Default from bundled SBML initial value."
}
],
"outputs": [
{
"name": "drug_metabolite_e3174",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.drug_metabolite_e3174"
},
{
"name": "drug_metabolite_e3174_2",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.drug_metabolite_e3174_2"
},
{
"name": "drug_metabolism_state_3",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.drug_metabolism_state_3"
},
{
"name": "drug_metabolism_state_4",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.drug_metabolism_state_4"
},
{
"name": "drug_metabolism_state_5_extracellular",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.drug_metabolism_state_5_extracellular"
},
{
"name": "observable_values",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.observable_values"
},
{
"name": "run_summary",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.run_summary"
},
{
"name": "observable_labels",
"maps_to": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.observable_labels"
}
]
},
"title": "Babaev2024 - CYP2C9 variants Lab",
"models": [
{
"path": "owned/models/metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model",
"alias": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model",
"parameters": {
"model_path": "data/MODEL2412180002.xml",
"integration_step": 0.1
},
"provenance": {
"owned_path": "owned/models/metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model_observable_values"
],
"from": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.observable_values"
},
{
"to": [
"visualisation.metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model_run_summary"
],
"from": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.run_summary"
},
{
"to": [
"visualisation.metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model_observable_labels"
],
"from": "metabolism_sbml_babaev2024_cyp2c9_variants_model2412180002_model.observable_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "Modified model of losartan metabolism (Karatza and Karalis, 2020) incorporating different allelic variants of CYP2C9. It can be used to explore metabolic flux dynamics and compare pathway behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.